Sign In
Buy ALEC
$1.78
-0.175 (-8.97%)
At Close: Jun 03, 2026
Bank of Montreal Can Increases Stock Holdings in Alector Inc (NASDAQ:ALEC)
11:03am, Friday, 27'th Mar 2020
Bank of Montreal Can boosted its position in Alector Inc (NASDAQ:ALEC) by 44.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,826 shares of the co
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 25.) * Ra Pharmaceuticals Inc (NASDAQ: RARX)Down In The
BidaskClub Lowers Alector (NASDAQ:ALEC) to Buy
11:06am, Thursday, 26'th Mar 2020
Alector (NASDAQ:ALEC) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Thursday, BidAskClub reports. ALE
Earnings Beat: Alector, Inc. (NASDAQ:ALEC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
10:11am, Thursday, 26'th Mar 2020
It's been a mediocre week for Alector, Inc. (NASDAQ:ALEC) shareholders, with the stock dropping 16% to US$23.45 in the...
Analysts Are Upgrading Alector, Inc. (NASDAQ:ALEC) After Its Latest Results
10:03am, Thursday, 26'th Mar 2020
There's been a notable change in appetite for Alector, Inc. (NASDAQ:ALEC) shares in the week since its full-year...
Alector Inc (NASDAQ:ALEC) Major Shareholder Sells $380,277.90 in Stock
09:30am, Thursday, 26'th Mar 2020
Alector Inc (NASDAQ:ALEC) major shareholder Orbimed Advisors Llc sold 14,598 shares of the business’s stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average pri
Alector Inc (NASDAQ:ALEC) Major Shareholder Orbimed Advisors Llc Sells 56,411 Shares
09:30am, Thursday, 26'th Mar 2020
Alector Inc (NASDAQ:ALEC) major shareholder Orbimed Advisors Llc sold 56,411 shares of the company’s stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $
BRIEF-Alector Inc - We Will Continue To Develop Al008 Globally
09:35pm, Wednesday, 25'th Mar 2020
Alector Inc:
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
09:00pm, Wednesday, 25'th Mar 2020
Alector, Inc. (ALEC), a clinical stage biotechnology company and leader in the discovery and development of therapeutics that harness the innate immune system, and Innovent Biologics, a leading Chines
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
09:00pm, Wednesday, 25'th Mar 2020
AL008 is Alector’s dual function SIRP-alpha inhibitor and Fc gamma receptor activator antibody targeting the innate immune system for oncology...
Cowen & Co. Sticks to Their Buy Rating for Alector (ALEC)
11:28pm, Tuesday, 24'th Mar 2020
In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on Alector (ALEC). The company's shares closed last Monday at
Cowen & Co. Sticks to Their Buy Rating for Alector (ALEC)
11:28pm, Tuesday, 24'th Mar 2020
In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on Alector (ALEC – Research
BRIEF-Alector Reports Q4 Loss Per Share Of $0.45
09:52pm, Tuesday, 24'th Mar 2020
Alector Inc:
Alector (ALEC) Reports Q4 Loss, Misses Revenue Estimates
09:25pm, Tuesday, 24'th Mar 2020
Alector (ALEC) delivered earnings and revenue surprises of -2.27% and -37.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Alector (ALEC) Reports Q4 Loss, Misses Revenue Estimates
09:25pm, Tuesday, 24'th Mar 2020
Alector (ALEC) delivered earnings and revenue surprises of -2.27% and -37.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
